8.7 C
Glasgow
Monday, February 23, 2026
spot_img

More News

Modifying CAR T-cells to kill solid tumours

Jim Cornall -
A team led by LMU physician Sebastian Kobold has found a way to allow the body’s immune system to...

New company created to tackle paediatric cerebral palsy

Jim Cornall -
Kidswell Bio Corporation and Treehill Partners are creating a new US-based regenerative medicine company, Kidswell USA. It is being formed...

Strategic partnership to advance space-based life sciences research infrastructure

Jim Cornall -
Azenta, Inc. has announced a strategic partnership with Frontier Space to conduct scientific experiments in space. The collaboration aims to...

HanchorBio receives FDA Orphan Drug Designation for gastric cancer drug

Jim Cornall -
HanchorBio, Inc. has announced that the U.S. Food and Drug Administration (FDA) granted Orphan Drug Designation (ODD) to its...

Collaboration to develop novel therapies for neutrophil-derived inflammatory diseases

Jim Cornall -
Evogene Ltd., Systasy Bioscience GmbH, and LMU University Hospital Munich, are set to collaborate to accelerate the development of...

Kainova Therapeutics raises C$32m to develop immuno-oncology and inflammation therapies

Jim Cornall -
Kainova Therapeutics has closed a Series B financing round of C$32m. The investment supports the clinical advancement of its GPCR-targeting...

AmacaThera named Life Sciences Ontario Emerging Company of the Year

Jim Cornall -
AmacaThera, a developer of next-generation hydrogel-based drug delivery solutions, has been named Emerging Company of the Year by Life...

Syngene and Johns Hopkins University to advance early-stage drug discovery

Jim Cornall -
Syngene International, a global contract research, development, and manufacturing organization (CRDMO), has announced a strategic collaboration with Johns Hopkins...

New model to study colorectal cancer

Jim Cornall -
Researchers at Åbo Akademi University in Finland have identified a new molecular change in patients with colorectal cancer and...

Creating a new option for treating diabetic retinopathy

Jim Cornall -
Breye Therapeutics ApS has presented clinical data showcasing the potential of its lead candidate, danegaptide at the Angiogenesis, Exudation,...

SPT Labtech and BellBrook Labs introduce high-throughput screening platform for cancer research

Jim Cornall -
SPT Labtech and BellBrook Labs have announced a collaboration to advance cancer research. Together, the companies have developed a...

Soin Neuroscience and Lilac Biosciences to collaborate to study RNA signatures in pain and neuromodulation

Jim Cornall -
Lilac Biosciences, a biotechnology company spun out of the Giuliani RNA Center at Brown University, which develops quantitative RNA-based...

Base to Base biotech podcast 46: Endometriosis and closing care gaps

Jim Cornall -
The conversations on this week’s podcast are with Vibhor Gupta, director and founder of Pangaea Data, and endogene.bio CEO...

Calla Lily Clinical Care and Merck to collaborate on intravaginal drug delivery platform

Jim Cornall -
Calla Lily Clinical Care and Merck have entered a strategic collaboration to support the continued development of Callavid, a...

Body’s own defence may be the key to longer cancer survival

Jim Cornall -
The findings from a large study led by the University of Helsinki highlight how certain ovarian cancer cells can...

Zonsen PepLib Biotech to collaborate with Lilly

Jim Cornall -
Zonsen PepLib Biotech Inc. (PepLib) has entered a global research and development collaboration and license agreement with Eli Lilly...

World-first personalised paediatric mRNA cancer vaccine trial

Jim Cornall -
Canadian company Providence Therapeutics is supporting a world-first clinical trial evaluating personalised mRNA cancer vaccines for children with advanced...

Orphan Drug Designation for cholangiocarcinoma treatment

Jim Cornall -
Partner Therapeutics, Inc. has announced that the U.S. Food and Drug Administration (FDA) has granted Orphan Drug Designation (ODD)...

Yeast cells can be used for rapid testing of cancer immunotherapy

Jim Cornall -
An international research team with strong participation from the Technical University of Denmark (DTU) has developed a new biotechnological...

Pfizer injectable shows continued weight loss in phase 2b trial

Jim Cornall -
Pfizer Inc. has announced positive topline results from its phase 2b VESPER-3 study investigating monthly maintenance dosing of its...

Skin damage protein ID could lead to new therapies

Jim Cornall -
Radiotherapy is one of the main treatment forms for cancer. Among its most common side effects is skin damage,...

Deeptech Digest is your guide to what's new in at the cutting edge of science technology. A bit of artificial intelligence, some biotech, and all the news and latests developments in the field. If it's deeptech, it's in Deeptech Digest!

Contact us: jim@deeptechdigest.com

© 2023 Ayr Coastal Media